Invex Therapeutics Ltd. (AU:IXC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Invex Therapeutics Ltd. has announced the expiration of 400,000 options on April 8, 2024, without exercise or conversion. The options were set to expire at a strike price of $0.91. This development may influence the company’s capital structure and potentially impact shareholder value.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.